Exogenous Ochronosis in Facial Lichen Planus Pigmentosus
Journal Title: Journal of Dermatology Research - Year 2021, Vol 2, Issue 1
Abstract
Lichen planus pigmentosus is a chronic inflammatory pigmentary dermatosis considered a rare variant of the cutaneous lichen planus. It is characterized by acquired dark brown to gray macular pigmentation involving sun-exposed areas commonly found in dark-skinned patients. Exogenous ochronosis is an acquired cause of blue-gray to black pigmentation involving the skin and mucous tissues. We report a case of exogenous ochronosis occurring in a 45-year-old patient treated for lichen planus pigmentosus. She was treated with Kligman formula containing hydroquinone. The patient presented to our Department for progressive worsening of the malar pigmentation. Dermoscopy revealed gray to black rounded and homogeneous areas with arciform structures obliterating the follicular openings and telangiectasic vessels making us suspecting exogenous ochronosis confirmed by histology.
Authors and Affiliations
Selma El Kadiri*, Hanane Bay Bay, Imane Kacimi, Zakia Douhi, Sara Elloudi, Fatima-Zahra Mernissi, Layla Tahiri, Nawal Hammas, Leila Chbani, Hinde El Fatemi
Keywords
Related Articles
- EP ID EP699063
- DOI http://dx.doi.org/10.46889/JDR.2021.2106
- Views 72
- Downloads 0
Radiofrequency Current at 448 Khz For Female Pattern Hair Loss: Cellular Bases For Redensification Improvement
Objective: Capacitive-Resistive Electrothermal Therapies (CRET) have proven effective in tissue regeneration. This study analyzes the response to 448-kHz CRET treatment in 20 patients with Female Pattern Hair Loss (FPHL)...
In-vivo Studies of Cosmetics with Ultraviolet Light Filter and Synergistic Antioxidant Care
The natural process of skin melanogenesis is an evolutionarily valuable mechanism that protects the human body against excessive exposure to solar radiation. Cosmetics with a filter are a very important invention of the...
Open-Label Crossover Oral Bioequivalence Pharmacokinetics Comparison of a Single Dose of Super-bioavailable Itraconazole 130 mg and Innovator SUBA®-Itraconazole Capsules 130 mg (2 x 65 mg) in Healthy Adults Under Fed Conditions
Introduction: Itraconazole (ITZ), an antifungal agent taken orally, demonstrates intricate and variable absorption kinetics, significantly impacted by food intake. The invention of Super-Bioavailable Itraconazole (SITZ)...
Human Protothecosis: Case Report of a Rare Algal Infection
Protothecosis: is a rare disease caused by opportunistic algae infection of the genus Prototheca. An 84-year-old female patient has presented with an erythematous, infiltrated, papulopustular plaque with areas of central...
The Role of Oral Cyclosporine in the Management of Steven Johnson Syndrome and Toxic Epidermal Necrolysis: A Retrospective Multicentric Observational Study
Background: SJS and TEN are severe life threatening muco-cutaneous reactions characterised by extensive epidermal sloughing with mucosal erosions. Objective: The main objective of this study was to observe the effectiv...